title: [Sonographically guided intralesional sclerotherapy for venous malformation].
abstract: OBJECTIVE
  To investigate the safety and efficacy of sonographically guided percutaneous intralesional sclerotherapy for peripheral venous malformations.
  
  
  METHODS
  From March 2004 to October 2007, 32 patients with venous malformations of soft tissues were treated with sonographically guided intralesional sclerotherapy. The malformed venous space was identified intraoperatively by duplex scanning, the gauge 7 needle was inserted into this venous space under real-time ultrasound visualization, and sclerosants were infused in the space gently. Absolute alcohol and bleomycin acted as sclerosants here, combined the two (for type I malformation) or bleomycin only (for type II malformation). The treatment could be repeated if the lesion was not cured in 3 weeks. All patients were followed up for 6 months to 2 years.
  
  
  RESULTS
  Of the group, each patient received 1 - 6 times of the therapy (mean, 3 times). Twenty-seven patients achieved a complete response, and 5 achieved partial response. No major complications occurred.
  
  
  CONCLUSIONS
  Sonographically guided percutaneous intralesional sclerotherapy for peripheral venous malformation is a simple, effective, safe therapy with minimal invasion, lower morbidity rate, and can be repeated.
authors.affiliation: Department of Plastic and Reconstructive Surgery, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China. drzhangli65@163.com
authors.forename: Li
authors.initials: L
authors.lastname: Zhang
authors.forename: Jun
authors.initials: J
authors.lastname: Wang
authors.forename: Cheng-shu
authors.initials: CS
authors.lastname: Zhang
authors.forename: Ping-hui
authors.initials: PH
authors.lastname: Zhou
authors.forename: Jing-yu
authors.initials: JY
authors.lastname: Qian
authors.forename: Xu-wen
authors.initials: XW
authors.lastname: Li
authors.forename: Shu-xing
authors.initials: SX
authors.lastname: Ge
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012597:Sclerosing Solutions / Q000008:administration & dosage; D015911:Sclerotherapy; D014463:Ultrasonography; D054079:Vascular Malformations / Q000000981:diagnostic imaging / Q000628:therapy*; D014680:Veins / Q000002:abnormalities* / Q000000981:diagnostic imaging
chemical_list: D012597:Sclerosing Solutions